共 15 条
[4]
Drug-eluting or bare-metal stents in subjects over 75 years of age: what is the best therapeutic strategy? Data from 460 consecutive patients with 1-year outcome[J] . Horma Ouldzein,Jérome Roncalli,Walid Zouaoui,Vanina Bongard,Nicolas Boudou,Nicolas Dumonteil,Thibaut Lhermusier,Meyer Elbaz,Jacques Puel,Didier Carrié.Cardiovascular Revascularization Medicine . 2009 (2)
[6]
Combined Impact of Age and Estimated Glomerular Filtration Rate on In-Hospital Mortality After Percutaneous Coronary Intervention for Acute Myocardial Infarction (from the American College of Cardiology National Cardiovascular Data Registry)
[J].
AMERICAN JOURNAL OF CARDIOLOGY,
2009, 103 (06)
:766-771
[7]
Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial[J] . Herbert D. Aronow,Steven R. Steinhubl,Danielle M. Brennan,Peter B. Berger,Eric J. Topol.American Heart Journal . 2009 (2)
[8]
Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy[J] . Olivier F. Bertrand,éric Larose,Josep Rodés-Cabau,Onil Gleeton,Isabelle Taillon,Louis Roy,Paul Poirier,Olivier Costerousse,Robert De Larochellière.American Heart Journal . 2009 (1)